News

Remiges Ventures to raise $150 mln venture-capital fund

Remiges Ventures has set out to raise a $150 million second venture-capital fund, according to a filing with the SEC.

Jumpspeed Ventures wraps up new fund

Jumpspeed Ventures, an Israeli venture firm, has closed its new fund at $17.7 million, according to an announcement on the site. Jumpspeed invests in early-stage startups based in Jerusalem.

Dawn Capital collects $125 mln for fourth fund: Reuters

Dawn Capital, an early-stage venture firm, has raised $125 million for its fourth fund, according to Reuters. The Dawn Capital Opportunities Fund targets European B2B tech companies.

Houston-based Mercury Fund raises more than $82 mln, seeks $125 mln

Houston, Texas-based Mercury Fund has raised $82.25 million of a $125 million targeted fourth fund, Mercury Fund Ventures IV, according to a regulatory filing. The fund is the firm's largest to date, having closed on $105 million in 2014. The commitments to date have come from 85 investors, according to the filing.

Revelstoke raises over $437 mln for sophomore fund

Revelstoke Capital Partners has raised over $437 million for its second fund, according to an SEC filing. No target was listed in the document. The Denver-based private equity firm invests in healthcare and related business services.

Sequoia Capital India collects $694.5 mln for sixth fund

Sequoia Capital India has raised $694.5 million for its sixth fund, according to an SEC filing. No target was listed in the document.

Great North Labs wraps up maiden fund at $23.7 mln

Great North Labs has closed its debut fund at $23.7 million. Great North Labs invests in tech startups based in the Upper Midwest.

Russian bank Sberbank and 500 Startups partner to run innovation accelerator in Moscow

Structure Capital to raise $50 mln venture fund

Structure Capital has set out to raise a $50 million venture-capital fund, according to a filing with the SEC.

Polaris targets $400 mln for ninth fund

Polaris Partners is seeking to raise $400 million for its ninth fund, according to an SEC filing. The Boston and San Francisco-based firm invests in healthcare and technology.